All 46 tested patients, mean age 30, and 11% with underlying respiratory disease had a negative serum anti-Aspergillus IgM/IgG antibody immunochromatographic test on day 3 (mean) of symptom onset (range 1–26), but follow up specimens to assess seroconversion were not available. This evidence concerns the gene CD40LG and respiratory system disorder.